Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines

References

• Cohen J. Infectious Diseases. 3rd Edition. Elsevier; 2010. p. 1143.
   Google Scholar
• Jakub SK, Campbell JD, Levine MM. Typhoid Vaccines. In: Zuckerman JN, Jung EC, editors. Travelers' Vaccines. 2nd Edition. Shelton, Connecticut, USA: People's Medical Publishing House; 2010. p. 164.
   Google Scholar
• Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis. 2006;42: 1247–1253. Epub 2006/04/06.
   PubMed Web of Science ®Google Scholar
• Levine MM. Typhoid fever vaccines. In: Plotkin SOW, Offit PA, editor. Vaccines. 6th ed. Philadelphia: WB Saunders Company; 2012. p. 812–836.
   Google Scholar
• Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet (London, England). 2005;366: 749–762. Epub 2005/08/30.
   PubMed Web of Science ®Google Scholar
• Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346–353. Epub 2004/08/10.
   PubMed Web of Science ®Google Scholar
• Mogasale V, Maskery B, Ochiai RL, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. 2014;2: e570–80. Epub 2014/10/12.
   PubMed Web of Science ®Google Scholar
• Crump JA. Updating and refining estimates of typhoid fever burden for public health action. Lancet Glob Health. 2014;2: e551–3. Epub 2014/10/12.
   PubMed Web of Science ®Google Scholar
• Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012;2:010401. Epub 2012/12/01.
   PubMedGoogle Scholar
• Connor BA, Schwartz E. Typhoid and paratyphoid fever in travellers. Lancet Infect Dis. 2005;5:623–628. Epub 2005/09/27.
   PubMed Web of Science ®Google Scholar
• WHO. Typhoid vaccines: WHO position paper. Weekly Epidemiological Record. 2008;83:49–60. .
   PubMedGoogle Scholar
• Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. Domi Typhoid study G. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86: 260–268. Epub 2008/04/29.
   PubMed Web of Science ®Google Scholar
• Chowta MN, Chowta NK. Study of clinical profile and antibiotic response in typhoid fever. Indian J Med Microbiol. 2005;23: 125–127. Epub 2005/06/02.
   PubMedGoogle Scholar
• Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011;5:324–337. Epub 2011/06/02.
   PubMed Web of Science ®Google Scholar
• Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010;50: 241–246. Epub 2009/12/18.
   PubMed Web of Science ®Google Scholar
• Date KA, Bentsi-Enchill A, Marks F, et al. Typhoid fever vaccination strategies. Vaccine. 2015;33 Suppl 3: C55–61. Epub 2015/04/23.
   PubMed Web of Science ®Google Scholar
• ECDC. Annual epidemiological report 2014 - food-and waterborne diseases and zoonoses 2014 [ cited 2016 Sep 09]. Available from: http://ecdc.europa.eu/en/publications/Publications/food-waterborne-diseases-annual-epidemiological-report-2014.pdf.
   Google Scholar
• CDC. CDC National typhoid and paratyphoid fever surveillance annual summary 2013 Atlanta, GA: US Department of Health and Human Services; 2015 [ cited 2016 Sep 09]. Available from: http://www.cdc.gov/ncezid/dfwed/pdfs/typhi-annual-summary-2013-508c.pdf.
   Google Scholar
• England PH Enteric fever surveillance quarterly report (England, Wales and Northern Ireland): first quarter 2016 2016 [ cited 2016 Sep 09]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/523390/hpr1716_ntrc-fvr.pdf.
   Google Scholar
• National Institute of Infectious Diseases. NESID Annual Sureillance Data (Notifiable Diseases) 2014-1 [ cited 2016 September 09]. Available from: http://www.nih.go.jp/.
   Google Scholar
• Kobayashi T, Kutsuna S, Hayakawa K, et al. Case Report: an outbreak of food-borne typhoid fever due to salmonella enterica serotype Typhi in Japan Reported for the first time in 16 years. Am J Trop Med Hyg. 2016;94: 289–291. Epub 2015/12/02.
   PubMed Web of Science ®Google Scholar
• Hancock-Allen J, Cronquist AB, Peden J, et al. Notes from the field: typhoid fever outbreak associated with an asymptomatic carrier at a restaurant - Weld County, Colorado, 2015. MMWR Surveill Summ. 2016;65: 606–607. Epub 2016/06/17.
   Google Scholar
• Yoon J, Segal-Maurer S, Rahal JJ. An outbreak of domestically acquired typhoid fever in Queens, NY. Arch Intern Med. 2004;164: 565–567. Epub 2004/03/10.
   PubMedGoogle Scholar
• Byers DK, Petersen K. A case of Salmonella enterica serotype typhi in a patient without a history of international travel. J Travel Med. 2009;16: 223–225. Epub 2009/06/23.
   PubMed Web of Science ®Google Scholar
• Sztein MB, Salerno-Goncalves R, McArthur MA. Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward. Front Immunol. 2014;5:516. Epub 2014/11/12.
   PubMed Web of Science ®Google Scholar
• Pham OH, McSorley SJ. Protective host immune responses to Salmonella infection. Future Microbiol. 2015;10: 101–110. Epub 2015/01/20.
   PubMed Web of Science ®Google Scholar
• Levine MM, Black RE, Lanata C. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis. 1982;146:724–726. Epub 1982/12/01.
   PubMed Web of Science ®Google Scholar
• Gunn JS, Marshall JM, Baker S, et al. Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence. Trends Microbiol. 2014;22: 648–655. Epub 2014/07/30.
   PubMed Web of Science ®Google Scholar
• Lin FY, Becke JM, Groves C, et al. Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol. 1988;26: 1194–1197. Epub 1988/06/01.
   PubMed Web of Science ®Google Scholar
• Hornick RB, Greisman SE, Woodward TE, et al. Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med. 1970;283: 739–746. Epub 1970/10/01.
   PubMed Web of Science ®Google Scholar
• Kumar R, Malaviya AN, Murthy RG, et al. Immunological study of typhoid: immunoglobulins, C3, antibodies, and leukocyte migration inhibition in patients with typhoid fever and TAB-vaccinated individuals. Infect Immun. 1974;10: 1219–1225. Epub 1974/12/01.
   PubMed Web of Science ®Google Scholar
• Tsang RS, Chau PY, Lam SK, et al. Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurement of serum antibodies by radioimmunoassay. Clin Exp Immunol. 1981;46: 508–514. Epub 1981/12/01.
   PubMed Web of Science ®Google Scholar
• Chau PY, Tsang RS, Lam SK, et al. Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay. Clin Exp Immunol. 1981;46: 515–520. Epub 1981/12/01.
   PubMed Web of Science ®Google Scholar
• Levine MM, Sztein MB, Pasetti MF. Module 20: salmonella enterica serovar Typhi (typhoid) vaccines. In: The immunological basis for immunisation series. Geneva, Switzerland: WHO; 2010.
   Google Scholar
• Pakkanen SH, Kantele JM, Kantele A. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine. 2012;30:6047–6053. Epub 2012/08/04.
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol. 2008;9: 981–987. Epub 2008/08/20.
   PubMed Web of Science ®Google Scholar
• Guzman CA, Borsutzky S, Griot-Wenk M, et al. Vaccines against typhoid fever. Vaccine. 2006;24: 3804–3811. Epub 2005/11/10.
   PubMed Web of Science ®Google Scholar
• CDC. Yellow Book - advising travelers with specific needs: immigrants returning home to visit friends relatives VFRS 2016 [ cited 2016 Sep 09]. Available from: http://wwwnc.cdc.gov/travel/yellowbook/2016/advising-travelers-with-specific-needs/immigrants-returning-home-to-visit-friends-relatives-vfrs.
   Google Scholar
• Bui YG, Trepanier S, Milord F, et al. Cases of malaria, hepatitis A, and typhoid fever among VFRs, Quebec (Canada). J Travel Med. 2011;18:373–378. Epub 2011/10/25.
   PubMed Web of Science ®Google Scholar
• Lester A, Mygind O, Jensen KT, et al. Typhoid and paratyphoid fever in Denmark 1986-1990. Epidemiologic aspects and the extent of bacteriological follow-up of patients. Ugeskr Laeger. 1994;156: 3770–3775. Epub 1994/06/20.
   Google Scholar
• Barrett FC, Knudsen JD, Johansen IS. Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse. BMC Res Notes. 2013;6: 315. Epub 2013/08/14.
   PubMedGoogle Scholar
• Seale H, Kaur R, Mahimbo A, et al. Improving the uptake of pre-travel health advice amongst migrant Australians: exploring the attitudes of primary care providers and migrant community groups. BMC Infect Dis. 2016;16:213. Epub 2016/05/20.
   PubMed Web of Science ®Google Scholar
• Dave J, Millar M, Maxeiner H, et al. East London experience with enteric fever 2007-2012. PloS One. 2015;10: e0120926. Epub 2015/03/20.
   PubMed Web of Science ®Google Scholar
• Reddy S, Rangaiah J, Addiman S, et al. Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010. Travel Med Infect Dis. 2011;9: 206–212. Epub 2011/06/04.
   PubMed Web of Science ®Google Scholar
• Papadimitropoulos V, Vergidis PI, Bliziotis I, et al. Vaccination against typhoid fever in travellers: a cost-effectiveness approach. Clin Microbiology Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2004;10: 681–683. Epub 2004/08/11.
   PubMed Web of Science ®Google Scholar
• Kariuki S, Gordon MA, Feasey N, et al. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33 Suppl 3: C21–9. Epub 2015/04/29.
   PubMed Web of Science ®Google Scholar
• Wong VK, Baker S, Pickard DJ, et al. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat Genet. 2015;47: 632–639. Epub 2015/05/12.
   PubMed Web of Science ®Google Scholar
• Wirth T. Massive lineage replacements and cryptic outbreaks of Salmonella Typhi in eastern and southern Africa. Nat Genet. 2015;47: 565–567. Epub 2015/05/29.
   PubMed Web of Science ®Google Scholar
• Azmatullah A, Qamar FN, Thaver D, et al. Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever. J Glob Health. 2015;5: 020407. Epub 2015/12/10.
   PubMed Web of Science ®Google Scholar
• Parry CM. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Vietnam. Trans R Soc Trop Med Hyg. 2004;98: 413–422. Epub 2004/05/13.
   PubMed Web of Science ®Google Scholar
• Ferreccio C, Levine MM, Rodriguez H, et al. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J Infect Dis. 1989;159: 766–769. Epub 1989/04/01.
   PubMed Web of Science ®Google Scholar
• Levine MM, Ferreccio C, Black RE, et al. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet (London, England). 1987;1:1049–1052.
   PubMed Web of Science ®Google Scholar
• Levine MM, Ferreccio C, Abrego P, et al. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine. 1999;17 Suppl 2: S22–7. Epub 1999/10/03.
   PubMed Web of Science ®Google Scholar
• Levine MM, Ferreccio C, Black RE, et al. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis. 2007;45 Suppl 1: S24–8. Epub 2007/07/14.
   PubMed Web of Science ®Google Scholar
• Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travelers: a nationwide study. J Travel Med. 2005;12: 275–281. Epub 2005/11/01.
   PubMed Web of Science ®Google Scholar
• Tagliabue A, Villa L, De Magistris MT, et al. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. Jl Immunolo (Baltimore, Md: 1950). 1986;137: 1504–1510. Epub 1986/09/01.
   PubMed Web of Science ®Google Scholar
• Wahid R, Fresnay S, Levine MM, et al. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans. Mucosal Immunol. 2015;8: 1349–1359. Epub 2015/04/16.
   PubMed Web of Science ®Google Scholar
• Wahid R, Simon R, Zafar SJ, et al. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans. Clinical Vaccine Immunology: CVI. 2012;19: 825–834. Epub 2012/04/12.
   PubMed Web of Science ®Google Scholar
• Pakkanen SH, Kantele JM, Kantele A. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains. Scand J Immunol. 2014;79: 222–229. Epub 2014/01/05.
   PubMed Web of Science ®Google Scholar
• Wahid R, Zafar SJ, McArthur MA, et al. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clinical Vaccine Immunology: CVI. 2014;21: 427–434. Epub 2014/01/17.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Koornhof HJ, Robbins JB, et al. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine. 1996;14:435–438.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Gilbertson IT, Koornhof HJ, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (London, England). 1987;2:1165–1169.
   PubMed Web of Science ®Google Scholar
• Typhim Vi summary of product characteristics [ cited 2016 Sep 05]. Available from: https://www.medicines.org.uk/emc/medicine/6186.
   Google Scholar
• Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A Preliminary Report. New Eng J Med. 1987;317:1101–1104.
   PubMed Web of Science ®Google Scholar
• Typherix summary of product characteristics: glaxoSmithKline UK; [ cited 2016 Sep 08]. Available from: https://www.medicines.org.uk/emc/medicine/2063.
   Google Scholar
• Anwar E, Goldberg E, Fraser A, et al. Vaccines for preventing typhoid fever. The Cochrane Database of Sys Rev. 2014;1:CD001261. Epub 2014/01/05.
   PubMed Web of Science ®Google Scholar
• Fraser A, Goldberg E, Acosta CJ, et al. Vaccines for preventing typhoid fever. The Cochrane Database of Sys Rev. 2007;3:CD001261. Epub 2007/07/20.
   PubMedGoogle Scholar
• Szu SC. Development of Vi conjugate - a new generation of typhoid vaccine. Expert Rev Vaccines. 2013;12:1273–1286. Epub 2013/10/26.
   PubMed Web of Science ®Google Scholar
• Mitra M, Shah N, Ghosh A, et al. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph) in Indian children: school based cluster randomized study. Hum Vaccin Immunother. 2016;12: 939–945. Epub 2016/02/24.
   PubMed Web of Science ®Google Scholar
• Darton TC, Jones C, Blohmke CJ, et al. Using a human challenge model of infection to measure vaccine efficacy: A randomised, controlled trial comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a. PLoS Negl Trop Dis. 2016;10:e0004926. Epub 2016/08/18.
   PubMed Web of Science ®Google Scholar
• MacLennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother. 2014;10: 1478–1493. Epub 2014/05/09.
   PubMed Web of Science ®Google Scholar
• FDA. Vivotif Package Insert USA [ cited 2016 Sep 08]. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094070.htm.
   Google Scholar
• Pasetti MF, Simon JK, Sztein MB, et al. Immunology of gut mucosal vaccines. Immunol Rev. 2011;239:125–148.
   PubMed Web of Science ®Google Scholar
• Kantele A, Kantele JM, Savilahti E, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. Jl Immunolo (Baltimore, Md: 1950). 1997;158: 574–579. Epub 1997/01/15.
   PubMed Web of Science ®Google Scholar
• Kantele JM, Arvilommi H, Kontiainen S, et al. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology. 1996;110: 1061–1067. Epub 1996/04/01.
   PubMed Web of Science ®Google Scholar
• Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ. 1994;72: 957–971. Epub 1994/01/01.
   PubMed Web of Science ®Google Scholar
• Kollaritsch H, Cryz SJ Jr., Lang AB, et al. Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization. Vaccine. 2000;18:3031–3039.
   PubMed Web of Science ®Google Scholar
• Tagliabue A, Nencioni L, Caffarena A, et al. Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol. 1985;62:242–247.
   PubMed Web of Science ®Google Scholar
• Schwartz E, Shlim DR, Eaton M, et al. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med. 1990;150: 349–351. Epub 1990/02/01.
   PubMedGoogle Scholar
• Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine. 1990;8: 321–326. Epub 1990/08/01.
   PubMed Web of Science ®Google Scholar
• Kantele A, Arvilommi H, Jokinen I. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis. 1986;153: 1126–1131. Epub 1986/06/01.
   PubMed Web of Science ®Google Scholar
• Kantele A, Arvilommi H, Kantele JM, et al. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb Pathog. 1991;10: 117–126. Epub 1991/02/01.
   PubMed Web of Science ®Google Scholar
• Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;10: 307–322. Epub 2011/03/26.
   PubMed Web of Science ®Google Scholar
• Whitaker JA, Franco-Paredes C, Del Rio C, et al. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med. 2009;16: 46–52. Epub 2009/02/05.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis. 2007;7:597–606.
   PubMed Web of Science ®Google Scholar
• Roggelin L, Vinnemeier CD, Fischer-Herr J, et al. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers. Vaccine. 2015;33:4141–4145.
   PubMed Web of Science ®Google Scholar
• Keitel WA, Bond NL, Zahradnik JM, et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine. 1994;12:195–199.
   PubMed Web of Science ®Google Scholar
• Lebacq E. Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration. BioDrugs. 2001;15 Suppl 1:5–12.
   PubMed Web of Science ®Google Scholar
• Overbosch D, Peyron F, Picot N, et al. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years. J Travel Med. 2005;12:319–326.
   PubMed Web of Science ®Google Scholar
• Zhou WZ, Koo HW, Wang XY, et al. Revaccination with locally-produced vi typhoid polysaccharide vaccine among Chinese school-aged children: safety and immunogenicity findings. Pediatr Infect Dis J. 2007;26:1001–1005.
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Capeding MR, Bavdekar A, et al. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014;14:119–129.
   PubMed Web of Science ®Google Scholar
• Moore SE, Jalil F, Szu SC, et al. Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight. Vaccine. 2008;26: 158–165. Epub 2007/12/11.
   PubMed Web of Science ®Google Scholar
• Nohynek H, Salmenlinna S, Matkailijan terveysopas: lavantauti. Terveyden Ja Hyvinvoinnin Laitos. [cited 2016 Sep 06]. Available from: http://www.terveyskirjasto.fi/terveyskirjasto/ktl.mat?p_artikkeli=mat00044.
   Google Scholar
• Bulletin Épidémiologique Hebdomadaire, Health recommendations for travelers, 2016 [cited 2016 Sep 05]. Available from: https://www.google.ch/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=0ahUKEwiSzb2Cq_jOAhXDtRoKHQqJA4wQFgglMAE&url=http%3A%2F%2Fwww.hcsp.fr%2FExplore.cgi%2FTelecharger%3FNomFichier%3Dhcsp_beh_2016.pdf&usg=AFQjCNHisACQwEbPmu5zyHJ_okID6Fbajw&bvm=bv.131783435,d.d2s.
   Google Scholar
• Deutsche Gesellschaft für Tropenmedizen und Internationalse Gesundheit (DTG), Hinweise und Empfehlungen zu Reiseimpfungen [updated 2016 May; cited 2016 Sep 05]. Available from: http://www.dtg.org/uploads/media/DTG_Impfungen_2016.pdf
   Google Scholar
• Koeman S Reis- En Vaccinatieadviezen: protocollen reizigersadvisering. Landelijk Coördinatiecentrum Reizgersadvisering (LCR) 2016 Feb [cited 2016 Sep 06]. Available from: http://www.mijnlcr.nl/.
   Google Scholar
• Pharmasuisse.org. Conseils de vaccination: vaccinations de base et vaccinations de voyage pour adultes [ cited 2016 Sep 06]. Available from: http://www.pharmasuisse.org/data/Oeffentlich/fr/Themen/Conseils_vaccination_2012_F.pdf.
   Google Scholar
• Public Health England, Green book [ cited 2016 Sep 08]. Available from: https://www.gov.uk/government/publications/typhoid-the-green-book-chapter-33.
   Google Scholar
• Typhoid and Paratyphoid Reference Group (TPRG), Public health operational guidelines for typhoid and paratyphoid (Enteric Fever): the health protection agency and the chartered institute of environmental health; February 2012 [cited 2016 Sep 05]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/355864/Public_Health_Operational_Guidelines_for_Enteric_Fever_v1.0_Feb_2012.pdf.
   Google Scholar
• Teh CS, Chua KH, Thong KL. Paratyphoid fever: splicing the global analyses. Int J Med Sci. 2014;11: 732–741. Epub 2014/06/07.
   PubMed Web of Science ®Google Scholar
• Martin LB, Simon R, MacLennan CA, et al. Status of paratyphoid fever vaccine research and development. Vaccine. 2016;34: 2900–2902. Epub 2016/04/17.
   PubMed Web of Science ®Google Scholar
• D’Amelio R, Tagliabue A, Nencioni L, et al. Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines. Infect Immun. 1988;56: 2731–2735. Epub 1988/10/01.
   PubMed Web of Science ®Google Scholar
• Nisini R, Biselli R, Matricardi PM, et al. Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits. Vaccine. 1993;11: 582–586. Epub 1993/01/01.
   PubMed Web of Science ®Google Scholar
• Tacket CO, Ferreccio C, Robbins JB, et al. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis. 1986;154: 342–345. Epub 1986/08/01.
   PubMed Web of Science ®Google Scholar
• Pakkanen SH, Kantele JM, Savolainen LE, et al. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Vaccine. 2015;33:451–458. Epub 2014/11/30.
   PubMed Web of Science ®Google Scholar
• Dong BQ, Yang J, Wang XY, et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ. 2010;88: 689–696. Epub 2010/09/25.
   PubMed Web of Science ®Google Scholar
• Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet (London, England). 1991;338: 1055–1059. Epub 1991/10/26.
   PubMed Web of Science ®Google Scholar
• Forrest BD. Impairment of immunogenicity of Salmonella typhi Ty21a due to preexisting cross-reacting intestinal antibodies. J Infect Dis. 1992;166: 210–212. Epub 1992/07/01.
   PubMed Web of Science ®Google Scholar
• Kantele A, Makela PH. Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine. 1991;9: 423–427. Epub 1991/06/01.
   PubMed Web of Science ®Google Scholar
• Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis. 2004;39: 186–191. Epub 2004/08/13.
   PubMed Web of Science ®Google Scholar
• Stubi CL, Landry PR, Petignat C, et al. Compliance to live oral Ty21a typhoid vaccine, and its effect on viability. J Travel Med. 2000;7: 133–137. Epub 2001/02/17.
   PubMed Web of Science ®Google Scholar
• Gilmartin HM. Provider-pharmacist education and adherence rates for the oral typhoid vaccine: a pilot study. J Travel Med. 2005;12: 113–114. Epub 2005/07/06.
   PubMed Web of Science ®Google Scholar
• Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24: S29–s34. Epub 2017/05/19.
   PubMedGoogle Scholar
• Arcilla MS, Van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17: 78–85. Epub 2016/10/19.
   PubMed Web of Science ®Google Scholar
• Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60: 837–846. Epub 2015/01/24.
   PubMed Web of Science ®Google Scholar
• Ruppe E, Armand-Lefevre L, Estellat C, et al. High rate of acquisition but short duration of carriage of multidrug-resistant enterobacteriaceae after travel to the tropics. Clin Infect Dis. 2015;61: 593–600. Epub 2015/04/24.
   PubMed Web of Science ®Google Scholar
• Kantele A, Mero S, Kirveskari J, et al. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study. Travel Med Infect Dis. 2017;16: 23–30. Epub 2017/02/06.
   PubMed Web of Science ®Google Scholar